Santen Pharmaceutical – World Class Benchmarking
Company: Santen Pharmaceutical Company Limited
Bloomberg ticker: 4536 JP
Market cap: US$4,532m
Background: Santen Pharmaceutical Company Limited is a Japanese pharmaceutical company, specializing in ophthalmology. With its ophthalmic products Santen holds the top share within the Japanese market and is one of the leading ophthalmic companies worldwide, with its products being sold in over 50 countries.
World Class Benchmarking of Santen Pharmaceutical
- Profitable Growth rank of 1 was up compared to the prior period’s 2nd rank
- This is World Class performance compared to 360 large Health Care companies worldwide
- Profitability rank of 3 was worse than its Growth rank of 1
- Profitability rank of 3 was the same compared to the prior period’s 3rd rank
- This is above average performance compared to peers
- Growth rank of 1 was up compared to the prior period’s 2nd rank
- This is World Class performance compared to peers
DISCLAIMER: This content is for information purposes only. It is not intended to be investment advice. Readers should not consider statements made by the author(s) as formal recommendations and should consult their financial advisor before making any investment decisions. While the information provided is believed to be accurate, it may include errors or inaccuracies. The author(s) cannot be held liable for any actions taken as a result of reading this article.